Listed

Curtiss Wright Corp: Form 10-Q for the period ended Jun 30, 2026

Filed with the SEC on Aug 6, 2026 and accepted by EDGAR at Aug 6, 2026, 19:04 ET.

Share

Management's discussion and analysis

As filed, 1,786 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following table provides information about our repurchase of equity securities that are registered by us pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, during the quarter ended June 30, 2026.

Total Number of shares purchased Average Price Paid per Share Total Number of Shares Purchased as Part of a Publicly Announced Program Maximum Dollar amount of shares that may yet be Purchased Under the Program
April 1 - April 30 6,952 $717.75 28,817 $235,470,777
May 1 - May 31 6,510 $730.26 35,327 230,716,797
June 1 - June 30 6,643 $750.99 41,970 225,727,957
For the quarter ended June 30, 2026 20,105 $732.78 41,970 $225,727,957

In November 2025, the Corporation entered into two written trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company implemented these written trading plans in connection with its previously announced share repurchase programs. The first trading plan includes purchases in the total amount of $60 million executed equally over the course of calendar year 2026. This written trading plan took effect on January 2, 2026 and will cease on December 31, 2026. The second trading plan includes potential purchases totaling $100 million. The Company cannot predict when or if it will purchase any additional shares of common stock as such plan includes a price limit where the Company would not buy shares under the Rule 10b5-1 plan. This written trading plan took effect on January 2, 2026 and will cease on December 31, 2026. The terms of the trading plans can be found in the Corporation's Form 8-K filed with the U.S. Securities and Exchange Commission on November 21, 2025.

Market risk

As filed, 304 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in our market risk during the six months ended June 30, 2026. Information regarding market risk and market risk management policies is more fully described in "Item 7A. Quantitative and Qualitative Disclosures about Market Risk" of our 2025 Annual Report on Form 10-K.

Controls and procedures

As filed, 1,482 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of June 30, 2026, our management, including our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of June 30, 2026 insofar as they are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and they include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

During the quarter ended June 30, 2026, there have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 228 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in our Risk Factors during the six months ended June 30, 2026. Information regarding our Risk Factors is more fully described in "Item 1A. Risk Factors" of our 2025 Annual Report on Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2026-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2026-04-01 to 2026-06-30$924.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2026-01-01 to 2026-06-30$1.84bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2026-04-01 to 2026-06-30$559.9mus-gaap:CostOfRevenue
Cost of revenue6 months2026-01-01 to 2026-06-30$1.14bnus-gaap:CostOfRevenue
Gross profit3 months2026-04-01 to 2026-06-30$364.1mus-gaap:GrossProfit
Gross profit6 months2026-01-01 to 2026-06-30$695.6mus-gaap:GrossProfit
Research and development3 months2026-04-01 to 2026-06-30$25.1mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2026-01-01 to 2026-06-30$49.3mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2026-04-01 to 2026-06-30$178.7mus-gaap:OperatingIncomeLoss
Operating income6 months2026-01-01 to 2026-06-30$338.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2026-04-01 to 2026-06-30$9.9mus-gaap:InterestExpenseNonoperating
Interest expense6 months2026-01-01 to 2026-06-30$19.9mus-gaap:InterestExpenseNonoperating
Income tax3 months2026-04-01 to 2026-06-30$43.1mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2026-01-01 to 2026-06-30$72.7mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2026-04-01 to 2026-06-30$151.2mus-gaap:NetIncomeLoss
Net income6 months2026-01-01 to 2026-06-30$279.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2026-04-01 to 2026-06-30$4.07us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2026-01-01 to 2026-06-30$7.53us-gaap:EarningsPerShareDiluted
Basic EPS3 months2026-04-01 to 2026-06-30$4.09us-gaap:EarningsPerShareBasic
Basic EPS6 months2026-01-01 to 2026-06-30$7.57us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2026-04-01 to 2026-06-3037,120,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2026-01-01 to 2026-06-3037,085,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2026-01-01 to 2026-06-30$175.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2026-01-01 to 2026-06-30$41.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2026-01-01 to 2026-06-30$8.9mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2026-01-01 to 2026-06-30$29.2mus-gaap:PaymentsForRepurchaseOfCommonStock
Current assetsAt period end2026-06-30$2.24bnus-gaap:AssetsCurrent
Total assetsAt period end2026-06-30$5.46bnus-gaap:Assets
Current liabilitiesAt period end2026-06-30$1.40bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2026-06-30$2.69bnus-gaap:Liabilities
Long-term debtAt period end2026-06-30$757.4mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2026-06-30$200.0mus-gaap:DebtCurrent
Shareholders' equityAt period end2026-06-30$2.77bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-26-054196. Last ingested by Listed: Oct 24, 2026, 14:52 ET. Listed shows no prices and gives no investment advice.